TABLE 1.
Parameters | No. of patients | Mean ± SD | P value |
---|---|---|---|
Gender | |||
Male | 75 | 6.1 ± 2.9 | .510 |
Female | 26 | 6.5 ± 3.0 | |
Age (y) | |||
<60 | 28 | 6.1 ± 2.9 | .811 |
≥60 | 73 | 6.2 ± 2.9 | |
Tumor size (cm) | |||
≤5 | 46 | 6.3 ± 3.4 | .776 |
>5 | 55 | 6.1 ± 2.4 | |
Differentiation | |||
Poor | 61 | 6.0 ± 2.6 | .610 |
Well‐moderate | 40 | 6.3 ± 3.4 | |
Invasion | |||
T1‐T3 | 28 | 4.9 ± 3.6 | .006 |
T4 | 73 | 6.7 ± 2.5 | |
Lymphatic metastasis | |||
N0 | 34 | 5.6 ± 3.7 | .148 |
N1‐N3 | 67 | 6.5 ± 2.4 | |
Distant metastasis | |||
M0 | 98 | 6.2 ± 2.9 | .384 |
M1 | 3 | 4.7 ± 1.0 | |
TNM stage | |||
I—II | 40 | 5.7 ± 3.5 | .200 |
III—IV | 61 | 6.5 ± 2.5 | |
CA19‐9 | |||
Negative | 79 | 6.0 ± 3.0 | .362 |
Positive | 22 | 6.5 ± 2.8 | |
Nervous invasion | |||
Absent | 84 | 5.9 ± 3.1 | .001 |
Present | 17 | 7.7 ± 1.3 | |
Perineural invasion | |||
Absent | 85 | 5.9 ± 3.1 | .003 |
Present | 16 | 7.4 ± 1.1 |